(Hackensack, NJ, March 2020) --The Consortium of Multiple Sclerosis Centers (CMSC) Annual Meeting scheduled for May 27-30, 2020 in [...]
People with MS have asked for guidance on the use of Disease Modifying Therapies (DMTs) during the COVID-19 pandemic. There are numerous [...]
Paris, France, March 10, 2020 – MedDay Pharmaceuticals announced today that the second pivotal Phase III trial (SPI2) of its [...]
As part of our commitment to ensuring healthy lives and promote well-being, we are providing you a list of resources related to coronavirus [...]
CHICAGO/WASHINGTON (Reuters) - The U.S. Centers for Disease Control and Prevention (CDC) on Tuesday alerted Americans to begin preparing [...]
The MS International Federation (also known as MSIF) has compiled information and a video (available here) which sufficiently [...]
The OPTIONS Study is looking at how well a study drug works for adults with relapsing-remitting multiple sclerosis (RRMS) who are currently [...]
